Portfolio company
Bioarchitech
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ventuno Biotech
This biotechnology company develops cancer immunotherapies to stimulate the immune system and treat patients with difficult tumours.
Vivere Oncotherapies
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
Arch Oncology
This biotechnology firm develops antibody therapies to treat patients with solid tumours and hematologic malignancies.
Stratosvir
This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.
Abalos Therapeutics
This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.
Siren Bio
This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.
Bactheravax
This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.
Theolytics
The company develops oncolytic viral immunotherapies for patients with solid tumours.
